How unified biological and chemical data strengthens early drug discovery decisions
How data limitations hold back AI in pharma R&D — and how organizations can reverse the trend
Empowering chemical innovators: Trends and strategies for effective IP search and analytics
Rethink IP search with human-centric AI
Green chemistry: Using IP and R&D trends to inform researchers and de-risk your IP portfolio
The business of biologics: Aligning IP search and monitoring strategies with market trends
Evolving IP strategies for semiconductor chemical innovation in a shifting geopolitical landscape
Clarity in biologics discovery
Beyond data silos: Five knowledge management tips to future-proof scientific R&D workflows
Turn untapped pharma data into R&D fuel: Three actionable steps to unlock AI predictive power
Five data barriers to safer small molecule drug development and how to overcome them
How can chemical companies thrive amid semiconductor supply chain disruptions?
CAS IP Research: Opportunities for Accelerating Innovation and Mitigating Risk at the Nexus of Intellectual Property and R&D
Reimagining supply chains to drive sustainability
From strategic data initiatives to therapeutic breakthroughs: Leveraging knowledge management to tackle drug repurposing challenges
Does your drug discovery budget fund novel ideas or data crunching?
What are the key trends in therapeutic fusion protein R&D?
Are IP and R&D misalignments slowing your drug development?
Is your pharmaceutical product development taking too long?
How is AI transforming the future of chemistry?
Do you know what's trending in drug discovery?
.avif)
Struggling to keep up with chemical industry innovation?
Profitable digital transformation
.avif)
Digital transformation in chemistry
